Interleukin-17 Inhibitors and the Potential Association of Systemic Lupus Erythematosus
{{output}}
Rationale & objective: Some patients with psoriasis develop lupus erythematosus-like side effects after treatment with interleukin (IL)-17 inhibitors. Whether use of IL-17 inhibitors increases the risk of systemic lupus erythemat... ...
